title: Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.
abstract: Women with the fragile X mental retardation 1 (FMR1) premutation often have concerns about neurological and medical problems, as they become older and if their fathers experience fragile X-associated tremor/ataxia syndrome (FXTAS). We therefore determined the prevalence of these problems in 110 daughters of men with FXTAS [mean age of 44.8 years (SD 8.2)]. We compared them with 43 female controls with normal FMR1 alleles [mean age of 43.8 years (SD 8.1)] and 36 premutation carrier daughters of parents with the premutation, but without FXTAS [mean age of 43.5 years (SD 7.7)]. Overall, daughters of men with FXTAS have a higher prevalence of neurological symptoms including tremor, balance problems, memory problems, and dizziness, menopausal symptoms, and psychiatric involvement including sleep problems and anxiety when compared with non-carrier female controls. Reported balance problems and menopausal symptoms were significantly higher in daughters of men with FXTAS than in carrier daughters of parents without FXTAS, suggesting the potential influence of background gene effects. Therefore, neurological, psychological and gynecological surveillance should be warranted to better provide appropriate counseling, management and care for daughters of men with FXTAS. Biological markers of additional gene effects that predispose individuals with the premutation to FXTAS need to be developed.
authors.affiliation: Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis Health System, Sacramento, CA 95817, USA.
authors.forename: W
authors.initials: W
authors.lastname: Chonchaiya
authors.forename: D V
authors.initials: DV
authors.lastname: Nguyen
authors.forename: J
authors.initials: J
authors.lastname: Au
authors.forename: L
authors.initials: L
authors.lastname: Campos
authors.forename: E M
authors.initials: EM
authors.lastname: Berry-Kravis
authors.forename: K
authors.initials: K
authors.lastname: Lohse
authors.forename: Y
authors.initials: Y
authors.lastname: Mu
authors.forename: A
authors.initials: A
authors.lastname: Utari
authors.forename: C
authors.initials: C
authors.lastname: Hervey
authors.forename: L
authors.initials: L
authors.lastname: Wang
authors.forename: P
authors.initials: P
authors.lastname: Sorensen
authors.forename: K
authors.initials: K
authors.lastname: Cook
authors.forename: L
authors.initials: L
authors.lastname: Gane
authors.forename: F
authors.initials: F
authors.lastname: Tassone
authors.forename: R J
authors.initials: RJ
authors.lastname: Hagerman
mesh_terms: D000328:Adult; D000368:Aged; D001259:Ataxia / Q000209:etiology; D016022:Case-Control Studies; D005220:Fathers; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000235:genetics* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D017410:Practice Guidelines as Topic; D015995:Prevalence; D014202:Tremor / Q000209:etiology
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1; C497683:FMR1 protein, human